home / stock / drrx / drrx articles
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, whic...
U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones falling around 80 points on Wednesday The Dow traded down 0.23% to 34...
Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares climbed 96% to $0.2921 after falling over 7% on Tuesday. GAN Limited (NASDAQ: GAN) sh...
DURECT Corporation (NASDAQ: DRRX) released topline results from its AHFIRM Phase 2b study of larsucosterol in 307 patients with seve...
U.S. stocks traded higher this morning, with the Dow Jones gaining around 90 points on Wednesday Following the market opening Wednesday, the Dow tr...
Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares surged 332% to $0.6455 in pre-market trading after falling over 7% on Tuesday. GAN Limi...
News, Short Squeeze, Breakout and More Instantly...
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update PR Newswire - Ongoing Communication with FDA to Align on Next Steps for Larsucosterol in Alcohol-Associated Hepatitis - Webcast of Earnings Call Today, M...
Cano Health Inc. Class A (CANOQ) is expected to report for Q4 2023 Cathay Pacific Airways Ltd. ADR (CPCAY) is expected to report for Q4 2023 NeuroSense Therapeutics Ltd. (NRSN) is expected to report for quarter end 2023-12-31 Bayerische Motoren Werke AG (BAMXF) is expected to report f...
DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update PR Newswire CUPERTINO, Calif. , March 20, 2024 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering th...